working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

Faron Pharmaceuticals CEO on encouraging BEXMAB trial results and the way forward

Companies: Faron Pharmaceuticals Oy

Faron Pharmaceuticals reports promising outcomes in cancer treatment trials; aiming for FDA approval

Companies: Faron Pharmaceuticals Oy

Faron Pharmaceuticals CEO on encouraging trial results and the way forward

Companies: Faron Pharmaceuticals Oy

Hardman & Co Healthcare Index: 2024 – Tough year for Life Sciences

Companies: TXG SYGGF INDVN Z29 TXG FARN 4BB PRM SUN AMS SN/ OMG EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC AREC ONT SLN IMCR ABDX

Faron Pharmaceuticals, ImmuPharma, KEFI Gold and Copper, Helium One, Satsuma Technology, Incanthera - Small Cap Snapshot

Companies: Faron Pharmaceuticals Oy

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top